Movement Alert｜Medtronic Rises 3.08% in Regular Trading, Sector Rebound Combined with Multiple Analyst Target Price Upgrades

Market Focus07-15 22:58

On July 15, Medtronic rose 3.08% in regular trading, trading at $81.69/share, with turnover of $173 million. The rebound follows a 3.53% decline in the prior session when the broader healthcare equipment sector came under significant pressure.

On the news front, multiple institutions recently raised their price targets on Medtronic. Baird adjusted its target from $85 to $91 while maintaining a Neutral rating, and BTIG raised its target from $90 to $91 while maintaining a Buy rating. According to FactSet, the analyst consensus rating on Medtronic is Overweight, with an average price target of $96.12, implying meaningful upside from the current share price.

Additionally, S&P recently revised Medtronic's outlook to positive, and Leerink noted that a September RNL coding review could represent a tailwind for the company. Medtronic reported its strongest annual revenue growth in a decade for fiscal 2026 and continues to advance its Hugo robotic surgery platform and cardiac ablation portfolio.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161729953?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161729953","market":"us","top_or_hot":-1,"title":"Movement Alert｜Medtronic Rises 3.08% in Regular Trading, Sector Rebound Combined with Multiple Analyst Target Price Upgrades","media":"Market Focus","content":"<p><p>On July 15, Medtronic rose 3.08% in regular trading, trading at $81.69/share, with turnover of $173 million. The rebound follows a 3.53% decline in the prior session when the broader healthcare equipment sector came under significant pressure.</p><p>On the news front, multiple institutions recently raised their price targets on Medtronic. Baird adjusted its target from $85 to $91 while maintaining a Neutral rating, and BTIG raised its target from $90 to $91 while maintaining a Buy rating. According to FactSet, the analyst consensus rating on Medtronic is Overweight, with an average price target of $96.12, implying meaningful upside from the current share price.</p><p>Additionally, S&P recently revised Medtronic's outlook to positive, and Leerink noted that a September RNL coding review could represent a tailwind for the company. Medtronic reported its strongest annual revenue growth in a decade for fiscal 2026 and continues to advance its Hugo robotic surgery platform and cardiac ablation portfolio.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medtronic Rises 3.08% in Regular Trading, Sector Rebound Combined with Multiple Analyst Target Price Upgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medtronic Rises 3.08% in Regular Trading, Sector Rebound Combined with Multiple Analyst Target Price Upgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-15 22:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 15, Medtronic rose 3.08% in regular trading, trading at $81.69/share, with turnover of $173 million. The rebound follows a 3.53% decline in the prior session when the broader healthcare equipment sector came under significant pressure.</p><p>On the news front, multiple institutions recently raised their price targets on Medtronic. Baird adjusted its target from $85 to $91 while maintaining a Neutral rating, and BTIG raised its target from $90 to $91 while maintaining a Buy rating. According to FactSet, the analyst consensus rating on Medtronic is Overweight, with an average price target of $96.12, implying meaningful upside from the current share price.</p><p>Additionally, S&P recently revised Medtronic's outlook to positive, and Leerink noted that a September RNL coding review could represent a tailwind for the company. Medtronic reported its strongest annual revenue growth in a decade for fiscal 2026 and continues to advance its Hugo robotic surgery platform and cardiac ablation portfolio.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDT","symbol_name":"美敦力","start_time":0,"source_url":"","article_id":"1161729953","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161729953","pubTimestamp":1784127533,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 15, Medtronic rose 3.08% in regular trading, trading at $81.69/share, with turnover of $173 million. The rebound follows a 3.53% decline in the prior session when the broader healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDT":"美敦力"},"translate_title":"走势警报|美敦力常规交易上涨3.08%，板块反弹叠加多位分析师目标价上调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1},"content_text":"On July 15, Medtronic rose 3.08% in regular trading, trading at $81.69/share, with turnover of $173 million. The rebound follows a 3.53% decline in the prior session when the broader healthcare equipment sector came under significant pressure.On the news front, multiple institutions recently raised their price targets on Medtronic. Baird adjusted its target from $85 to $91 while maintaining a Neutral rating, and BTIG raised its target from $90 to $91 while maintaining a Buy rating. According to FactSet, the analyst consensus rating on Medtronic is Overweight, with an average price target of $96.12, implying meaningful upside from the current share price.Additionally, S&P recently revised Medtronic's outlook to positive, and Leerink noted that a September RNL coding review could represent a tailwind for the company. Medtronic reported its strongest annual revenue growth in a decade for fiscal 2026 and continues to advance its Hugo robotic surgery platform and cardiac ablation portfolio.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161729953","isCrawlerRequest":true}